Teleflex (NYSE:TFX) announced today that it completed its acquisition of Standard Bariatrics and its powered stapling technology.
Wayne, Pennsylvania-based Teleflex announced its acquisition of Cincinnati, Ohio-based Standard Bariatrics last month.
The definitive agreement included a $170 million price for the bariatric surgery technology developer at closing. Teleflex could pay up to an additional $130 million upon the achievement of certain commercial milestones.
According to a news release, the acquisition won’t contribute meaningfully to Teleflex’s 2022 revenue. The company expects it to be approximately 10¢ dilutive to adjusted earnings per share.
In 2023, Teleflex expects the transaction to contribute between $30 million and $35 million in revenue. Teleflex expects it to be approximately 10¢ to 15¢ dilutive in adjusted EPS. It expects it to be accretive to revenue growth and adjusted EPS thereafter.
Standard Bariatrics des…